Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.32 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.31 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.31 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.30 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.30 |
| ▸ | CPT2 | P23786 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2133644 | 0.98 | RNPEP (0.32) | EPHX1RNPEPSLC7A5FOLH1 | |
| SCHEMBL2135338 | 0.94 | RNPEP (0.32) | EPHX1RNPEPSLC7A5FOLH1 | |
| SCHEMBL2134546 | 0.89 | CYSLTR2 (0.35) | EPHX1RNPEPSLC7A5FOLH1 | |
| SCHEMBL2133156 | 0.89 | CYSLTR2 (0.35) | EPHX1RNPEPSLC7A5FOLH1 | |
| SCHEMBL2137201 | 0.88 | CYSLTR2 (0.33) | EPHX1RNPEPSLC7A5FOLH1 | |
| SCHEMBL2131678 | 0.87 | EPHX1 (0.31) | EPHX1RNPEPSLC7A5 | |
| SCHEMBL2135976 | 0.85 | EPHX1 (0.30) | EPHX1 | |
| SCHEMBL2134953 | 0.85 | NOS3 (0.33) | EPHX1 | |
| SCHEMBL2133742 | 0.85 | RNPEP (0.31) | EPHX1RNPEPSLC7A5FOLH1 | |
| SCHEMBL2135466 | 0.84 | EPHX1 (0.33) | EPHX1FFAR1CPT2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120101294-A1 | PROCESS FOR PRODUCING (FLUOROALKYLTHIO) ACETIC ACID ESTER | GRHPR, AKR7A2, FAR1 | EPHX1 2018/4885RNPEP 1177/4885SLC7A5 1638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.